Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112

NCT05638165 is registered in ClinicalTrials.gov with NovaCell Technology Inc. as lead sponsor.

NCT NCT05638165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05638165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112
Lead sponsor
NovaCell Technology Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 13, 2021
Completion date
November 20, 2021
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis